-
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Consensus Rating of "Buy" by Brokerages
Источник: Buzz FX / 28 ноя 2024 03:51:10 America/New_York
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Consensus Rating of "Buy" by Brokerages Written by MarketBeat November 28, 2024 Share Link copied to clipboard. Day One Biopharmaceuticals, Inc. ( NASDAQ:DAWN - Get Free Report ) has rece
Read more...